6.09.2009
Weill and Columbia Scientists Announce Transgenic Mouse Model
>
Scientists from Columbia and Cornell have announced a new Transgenic mouse model version relating to Parkinson's Disease. Here's the abstract from Nature Neuroscience:
The Full article is here
Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease. We created a LRRK2 transgenic mouse model that recapitulates cardinal features of the disease: an age-dependent and levodopa-responsive slowness of movement associated with diminished dopamine release and axonal pathology of nigrostriatal dopaminergic projection. These mice provide a valid model of Parkinson's disease and are a resource for the investigation of pathogenesis and therapeutics.
The Full article is here
Labels: LRRK2, mouse, transgenic
